Patents Represented by Attorney, Agent or Law Firm Felfe & Lynch
  • Patent number: 5696232
    Abstract: The present invention is directed to Listeria monocytogenes specific protein that is encoded by nucleotide sequence of FIG. 1, the complementary sequence of which hybridizes to the nucleotide sequence of FIG. 1 at 5-6x SSC and 42.degree.-60.degree. C. A Listeria monocytogenes specific protein is also described having an amino aicd sequence as set forth in FIGS. 1A-1D. The proteins are suitable for the production of antibodies against Listeria monocytogenes.
    Type: Grant
    Filed: June 2, 1995
    Date of Patent: December 9, 1997
    Assignee: Boehringer Amnnheim GmbH
    Inventors: Trinad Chakraborty, Werner Goebel, Servatius Hubertus Wilhelmus Notermans
  • Patent number: 5696683
    Abstract: In order to optimize control of drive slip, the torque demand of the drive is determined continuously taking into account the interfering torques acting on the vehicle, and the drive torque is reduced to this torque demand when instability occurs.
    Type: Grant
    Filed: October 23, 1995
    Date of Patent: December 9, 1997
    Assignee: Robert Bosch GmbH
    Inventors: Jochen Schafer, Thomas Sauter
  • Patent number: 5694883
    Abstract: The present invention relates to a method of cultivating, in medium, Steinernema kushidai (hereinafter simply called kushidai) which is one type of Nematoda. Kushidai has a strong insecticidal ability to kill larvae of coliopterous insects, and cultivation of large quantities of kushidai having the strong insecticidal ability requires conditions different from the techniques of cultivating other nematodes parasitic on insects.Kushidai is cultivated in a medium including asteroid. This increases the insecticidal activity with respect to insects harmful to plants such as crops. The medium including asteroid may be adsorbed to a plurality of supports, and then the supports may be stacked with gaps thereamong to form a layer. This enables kushidai to be cultivated efficiently. Further, a liquid medium including asteroid may be prepared, with cultivation carried out while agitating the medium and supplying oxygen thereto.
    Type: Grant
    Filed: January 29, 1996
    Date of Patent: December 9, 1997
    Assignee: Kubota Corporation
    Inventors: Mineo Tachibana, Toshihito Uechi, Nobukazu Suzuki, Tadaaki Kawasugi
  • Patent number: 5694636
    Abstract: A photographic processing apparatus includes a main drive roller mechanism for transporting a photosensitive material in forward and reverse transport directions along a transport passage. The apparatus also includes forward and reverse drive roller mechanisms for assisting the main drive roller mechanism. The forward and reverse drive roller mechanisms are disposed upstream of the main drive roller mechanism relative to the forward transport direction. At least the forward and reverse drive roller mechanisms are supplied with power by a common drive source. The forward drive roller mechanism includes a first one-way clutch mechanism for restricting the rotational force supplied from the drive source when the photosensitive material is transported reversely. The reverse drive roller mechanism includes a second one-way clutch mechanism for restricting the rotational force supplied from the drive source when the photosensitive material is transported forwardly.
    Type: Grant
    Filed: January 16, 1996
    Date of Patent: December 2, 1997
    Assignee: Noritsu Koki Co., Ltd.
    Inventors: Mitsuhiko Itojima, Teruhito Oka
  • Patent number: 5693754
    Abstract: The invention provides homogeneous compositions of a binding protein for insulin-like growth factors (IGFs) I and II, which binding protein inhibits the proliferative effects of IGF-I and IGF-II upon bone cells. The homogeneous protein of the invention is therefore known as inhibitory IGF binding protein, or In-IGF-BP. The invention also provides cloned nucleic acid sequences encoding In-IGF-BP, artificial expression systems for In-IGF-BP and host cells which produce useful quantities of In-IGF-BP. The invention further provides clinical diagnostic assays for IGFs, therapeutic treatments for IGF-responsive tumors, and means for modulating IGF activity upon bone cells.
    Type: Grant
    Filed: October 22, 1992
    Date of Patent: December 2, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: David J. Baylink, Subburaman Mohan
  • Patent number: 5690745
    Abstract: A treatment chamber (1) evacuable by vacuum pumps (13,13') has a mounting (26,26', . . .) bearing the hollow body (4) in the treatment chamber (1), and a line (9,9') for the admission of a process gas into the treatment chamber (1). A microwave conductor (20,20' . . .) is connected with a generator (19,19' . . .) for igniting a plasma in the area of channels formed by a sheet-metal shroud (2,2') matching the configuration of the hollow body (4). A closure (7,7') is provided through which the filler opening (6, 6') of the hollow body (4) can be closed pressure-tight, and a line (9,9') for the process gas passes through the closure.
    Type: Grant
    Filed: October 17, 1995
    Date of Patent: November 25, 1997
    Assignee: Leybold AG
    Inventors: Heinrich Grunwald, Hermann Kloberdanz, Roland Lacher, Siang-Hong Boll
  • Patent number: 5690891
    Abstract: In a process for the production of alloys from at least two alloy components (A, B, C, D, . . . ) with different melting points by melting in an inductively heated cold-walled crucible (1) with a cooled crucible base (3), in order to obtain an exact and homogeneous alloy composition at least a part of the alloy components (A, B, C, D, . . . ) are introduced into the cold-walled crucible (1) consecutively and in stacked fashion where eithera) the alloy component (a) in each case with the lower melting point is introduced first orb) the alloy component in each case with the lower density is introduced firstand following the introduction at least one of further alloy component the heating energy is switched on. The process serves preferably for the production of the intermetallic phase TiAl, where firstly the aluminium and then the titanium are stacked in the cold-walled crucible (1).
    Type: Grant
    Filed: January 30, 1996
    Date of Patent: November 25, 1997
    Assignee: Ald Vacuum Technologies GmbH
    Inventors: Alok Choudhury, Matthias Blum, Harald Scholz, Georg Jarczyk
  • Patent number: 5690094
    Abstract: A gas-flame heated, self-contained kettle comprises a housing (12); a gas burner (14) contained within the housing (12); a container (16) for the fluid (18) to be heated, positioned within the housing (12) and above the burner(14); and exhaust duct (22) leading from an area (24) above the burner (14), through the container (16), and out of a surface of the housing (12). Excess heat and combustion gases are exhausted in heat-exchanged contact with fluid in the container (16) via the ducts (22), for augmented heating of the fluid with simultaneous protection and insulation of the housing (12).
    Type: Grant
    Filed: May 8, 1996
    Date of Patent: November 25, 1997
    Assignee: Etzion Metal Works
    Inventors: Naftali Sheinfeld, Shmuel Huss, Ilya Shmuelson
  • Patent number: 5690931
    Abstract: Discussed are therapeutic approaches to the treatment of thrombolic conditions. The therapies use thrombolytically active proteins which function by, e.g., inhibiting reocclusion in the subject. The proteins are administered in two or more boli.
    Type: Grant
    Filed: March 25, 1994
    Date of Patent: November 25, 1997
    Assignee: Boehringer Mannheim GmbH
    Inventors: Ulrich Martin, Reinhard Konig
  • Patent number: 5688947
    Abstract: In order to produce a purine of the general formula (I), ##STR1## in which R.sup.1 and R.sup.2 can be the same or different and denote H, OH, SH, NH.sub.2, N-(di)-alkyl, halogen, O-alkyl, S-alkyl, alkyl or aryl and alkyl represents an aliphatic residue with 1 to 4 carbon atoms and aryl represents a phenyl residue which is substituted if desired by CH.sub.3, OH, NH.sub.2 or halogen, from the corresponding 4-amino-5-nitrosopyrimidine of formula (II), ##STR2## in which R.sup.1 and R.sup.2 have the above-mentioned meaning, the compound of formula (II) is reductively formylated in a solvent at a temperature of 80.degree. to 220.degree. C. in the presence of formic acid and a catalyst based on a noble metal and the 4-amino-5-formylaminopyrimidine formed as an intermediate is cyclized.
    Type: Grant
    Filed: June 26, 1995
    Date of Patent: November 18, 1997
    Assignee: Skw Trostberg Aktiengesellschaft
    Inventors: Franz Thalhammer, Jurgen Graefe
  • Patent number: 5689326
    Abstract: A photographic printing apparatus includes an exposing device (5) for printing an image of a photographic film (2) on printing paper (3), a supplementary information exposing device (6) for printing supplementary information, such as a date, time and place of photographing, on part of the printing paper (3), and ND filters (31) or a liquid crystal panel (45, 46) for suppressing light projected to a selected region within a print region when the image of the photographic film (2) is printed on the printing paper (3). The supplementary information exposing device (5) prints the supplementary information in the selected region.
    Type: Grant
    Filed: September 5, 1996
    Date of Patent: November 18, 1997
    Assignee: Noritsu Koki Co., Ltd
    Inventors: Junji Yamada, Toru Tanibata
  • Patent number: 5687731
    Abstract: An oscillometric method for determining hemodynamic parameters of the arterial portion of patient's circulatory system, consisting in recording the pulse pressure waves in the major arterial vessel under examination, under the effect of a linearly varying pressure in a pneumatic vessel-constricting pressure cuff, with the result that a closed contour is formed within a single measuring cycle, which is established by straight lines the points of intersection of which are the signs of arterial pressure, while the amplitude values of the pulse waves in the contour determine the geometric parameters of the major arterial vessel under examination. A measuring system for carrying the method into effect features a linear characteristic of conversion and a straight horizontal amplitude-frequency characteristic in a frequency range of approximately from 0 to 50 Hz along a through path of conversion, amplification, and recording.
    Type: Grant
    Filed: November 8, 1994
    Date of Patent: November 18, 1997
    Assignee: MTI, Ltd.
    Inventors: Viacheslav Nikolaievich Ragozin, Vladimir Alexandrevitch Degtiarev
  • Patent number: 5688388
    Abstract: Pole shoes (3, 4, 5) of magnetically conductive material are provided inside of a first tubular target (2). Outside the target (2), a magnetic flux guide element (7) is provided, which has three pole shoes (8, 9, 10) directed toward the hollow body (1), which are connected to each other by magnets (12, 13). These magnets (12, 13) transmit the magnetic field through the target (2) to the pole shoes (3, 4, 5) inside the target (2) across narrow gaps (6, 11).
    Type: Grant
    Filed: July 29, 1996
    Date of Patent: November 18, 1997
    Assignee: Balzers und Leybold Deutschland Holding AG
    Inventors: Martin Bahr, Gunter Brauer, Erwin Winter
  • Patent number: 5688692
    Abstract: The provision of cell lines from virtually any cell type of the animal body is greatly facilitated by transgenic non-human eukaryotic animals of the invention in which at least some cells have (i) a differentiation inhibiting sequence chromosomally incorporated under the control of a non-constitutive promotor and/or (ii) a differentiation inhibiting sequence which is itself conditionally active. Said genes are chromosomally incorporated under the control of a promotor such that expression of said sequence is normally held below an effective level, thus allowing normal cell development. However, cells taken from said animal may be prevented from completing differentiation to a non-dividing state in tissue culture by activating expression of said sequence.
    Type: Grant
    Filed: February 11, 1993
    Date of Patent: November 18, 1997
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Parmjit Singh Jat, Dimitris Kioussis, Mark David Noble
  • Patent number: 5688340
    Abstract: Disclosed is a process in which a phosphate layer is formed on a metal surface in preparation for the subsequent application of a vitreous enamel coating, wherein a phosphating solution is used which contains essentially nickel and/or cobalt as a layer-forming cation in amounts of 0.5 to 3 g/l as well as5 to 20 g/l phosphate (calculated as P.sub.2 O.sub.5),0.1 to 0.5 g/l molybdate (calculated as MoO.sub.3),0.2 to 2 g/l fluoride (calculated as F),1 to 10 g/l nitrate (calculated as NO.sub.3),and optionally also 0.1 to 5 g/l urea.It is particularly desirable to use essentially zinc-free phosphating solutions at temperatures preferably of 60.degree. to 70.degree. C. for 2 to 12 minutes to form a phosphate layer having a coating weight of 1.0 to 2.0 g/m.sup.2.
    Type: Grant
    Filed: August 22, 1995
    Date of Patent: November 18, 1997
    Assignee: Metallgesellschaft Aktiengesellschaft
    Inventors: Margit Fleischhacker-Jeworrek, Dieter Jentsch, Klaus Wittel
  • Patent number: 5686194
    Abstract: A laminated steel sheet for dry forming drawn and ironed cans wherein the steel sheet comprises a steel containing iron, carbon, manganese, aluminum, silicon, phosphorus, sulfur and optionally titanium and/or niobium and wherein the steel sheet is electrolytically chromium-coated and covered on both sides with a 10-50 .mu.m thick thermoplastic resin layer. The sheet sheet has a crystal grain size of 8-30 .mu.m, a surface roughness of 0.05-0.6 .mu.m and a thickness of 0.15-0.3 mm.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: November 11, 1997
    Assignee: Toyo Kohan Co., Ltd.
    Inventors: Keiichi Shimizu, Humio Kunishige, Junichi Tanabe, Atsuo Tanaka
  • Patent number: 5686267
    Abstract: A vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi. The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies and antigens.
    Type: Grant
    Filed: March 20, 1995
    Date of Patent: November 11, 1997
    Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenscaften E.V., Deutsches Krebsforschun Zentrum Stiftung des Offentlichen Rechts
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard
  • Patent number: 5686068
    Abstract: New peptides derived from the MAGE-2 molecule and which bind to HLA-A*0201 molecules are disclosed. Some of these are especially useful because, when complexed to their HLA-A*0201 partner molecules, they induce CTL proliferation.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: November 11, 1997
    Assignees: Ludwig Institute for Cancer Research, Leiden University
    Inventors: Cornelius J. M. Melief, M. W. Visseren, Sjoerd van der Burg, Pierre van der Bruggen, Thierry Boon-Falleur
  • Patent number: D385979
    Type: Grant
    Filed: September 12, 1996
    Date of Patent: November 4, 1997
    Assignee: Carl Freudenberg
    Inventor: Gerhard Berger
  • Patent number: D387068
    Type: Grant
    Filed: November 28, 1995
    Date of Patent: December 2, 1997
    Assignee: Kubota Corporation
    Inventors: Hisato Kato, Mitsuhiko Obe, Seiichi Takahashi